<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02318810</url>
  </required_header>
  <id_info>
    <org_study_id>A 2014 1212</org_study_id>
    <nct_id>NCT02318810</nct_id>
  </id_info>
  <brief_title>Influence of the Neuromuscular Blockade on Mask Ventilation</brief_title>
  <official_title>The Influence of the Neuromuscular Blockade on Mask Ventilation; a Placebo Controlled, Randomized Trial With Three Different Dosages of Rocuronium (0.3 mg/kg, 0.6 mg/kg and 0.9 mg/kg)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Rostock</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Rostock</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Mask ventilation during induction of anesthesia can be improved by administration of
      neuromuscular blocking agents (NMBAs). NMBAs are usually administered after testing mask
      ventilation; however, muscle relaxants may improve mask ventilation and they do not alter
      mask ventilation. Thus, growing evidence suggests to administer muscle relaxants before
      testing mask ventilation. We will study different dosages of rocuronium; we assume that
      higher dosages of rocuronium will improve mask ventilation compared with lower dosages.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Mask ventilation during induction of anesthesia can be improved by administration of
      neuromuscular blocking agents (NMBAs). NMBAs are usually administered after testing mask
      ventilation; however, muscle relaxants may improve mask ventilation and they do not alter
      mask ventilation. Thus, growing evidence suggests to administer muscle relaxants before
      testing mask ventilation.We will administer rocuronium 0.3 mg/kg, 0.6 mg/kg, 0.9 mg/kg and
      saline (placebo group) before starting with mask ventilation. We will grade mask ventilation
      based on various scores before and after rocuronium application. Afterwards patient`s
      tracheas will be intubated. We assess risk factors for difficult mask ventilation.

      We hypothesize that rocuronium 0.9 mg/kg will be superior to rocuronium 0.3 mg/kg and saline.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2015</start_date>
  <completion_date type="Actual">May 2016</completion_date>
  <primary_completion_date type="Actual">May 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of improved mask ventilation after rocuronium administration</measure>
    <time_frame>Two minutes after rocuronium administration</time_frame>
    <description>Graded with various scores</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">300</enrollment>
  <condition>Complication of Ventilation Therapy</condition>
  <condition>Observation of Neuromuscular Block</condition>
  <arm_group>
    <arm_group_label>Rocuronium 0.3 mg/kg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients receive rocuronium 0.3 mg/kg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Rocuronium 0.6 mg/kg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients receive rocuronium 0.6 mg/kg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Rocuronium 0.9 mg/kg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients receive rocuronium 0.9 mg/kg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients receive saline</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Rocuronium 0.3 mg/kg</intervention_name>
    <description>Patients receive rocuronium 0.3 mg/kg</description>
    <arm_group_label>Rocuronium 0.3 mg/kg</arm_group_label>
    <other_name>Esmeron</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Rocuronium 0.6 mg/kg</intervention_name>
    <description>Patients receive rocuronium 0.6 mg/kg</description>
    <arm_group_label>Rocuronium 0.6 mg/kg</arm_group_label>
    <other_name>Esmeron</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Rocuronium 0.9 mg/kg</intervention_name>
    <description>Patients receive rocuronium 0.9 mg/kg</description>
    <arm_group_label>Rocuronium 0.9 mg/kg</arm_group_label>
    <other_name>Esmeron</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Patients receive saline</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with ASA I-III

          -  required tracheal intubation

          -  informed consent

        Exclusion Criteria:

          -  known allergy against anesthetics

          -  known difficult airway
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas Mencke, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Rostock</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Anesthesia and Intensive Care Medicine, University of Rostock</name>
      <address>
        <city>Rostock</city>
        <state>Mecklenburg/Vorpommern</state>
        <zip>18057</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 12, 2014</study_first_submitted>
  <study_first_submitted_qc>December 12, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 17, 2014</study_first_posted>
  <last_update_submitted>May 2, 2016</last_update_submitted>
  <last_update_submitted_qc>May 2, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 3, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Rostock</investigator_affiliation>
    <investigator_full_name>Thomas Mencke</investigator_full_name>
    <investigator_title>Prof. Dr. Thomas Mencke</investigator_title>
  </responsible_party>
  <keyword>Muscle relaxants</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rocuronium</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

